Allergy Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Allergy Therapeutics's balance sheet done over the years? Its assets were worth $64,827,000 last year, which is less than in the previous period. 94% of Allergy Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $61,118,000, which means an increase by 74% compared compared to last year.
Debt to Assets
| 2011 | 30621000 | 28.48M | 93.01% |
|---|---|---|---|
| 2012 | 27754000 | 13.16M | 47.42% |
| 2015 | 50699000 | 16.23M | 32.01% |
| 2016 | 56679000 | 26.35M | 46.5% |
| 2018 | 51016000 | 27.98M | 54.85% |
| 2019 | 68497000 | 30.93M | 45.17% |
| 2020 | 86225000 | 42.44M | 49.22% |
| 2021 | 88089000 | 39.55M | 44.9% |
| 2022 | 72948000 | 35.18M | 48.23% |
| 2024 | 64827000 | 61.11M | 94.28% |
AGY.L Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 12.91M | 20.51M | 40.27M | 36.96M | 27.44M | 15.53M | 23.40M | 21.19M | 903K | 1.04M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | -10.33M | 783K | 483K | 0 |
Net receivables | 7.82M | 10.46M | 6.22M | 8.07M | 4.49M | 6.58M | 5.51M | 3.23M | 0 | 0 |
Inventory | 12.74M | 11.41M | 10.83M | 10.13M | 9.40M | 8.80M | 7.69M | 6.74M | 6.65M | 7.08M |
Other current assets | 0 | 7.77M | 525K | 4.58M | 5.28M | 2.76M | 1.77M | 1.83M | 4.99M | 6.77M |
Total current assets | 33.48M | 42.39M | 57.85M | 55.17M | 46.62M | 30.92M | 37.61M | 33.78M | 13.03M | 14.91M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 23.74M | 20.19M | 19.71M | 20.41M | 11.48M | 10.09M | 9.66M | 8.75M | 7.55M | 8.80M |
Goodwill | 3.31M | 3.34M | 3.34M | 3.46M | 3.43M | 3.40M | 3.27M | 2.98M | 2.48M | 2.62M |
Intangible assets | 1.37M | 5.03M | 4.75M | 4.73M | 1.40M | 1.54M | 2.08M | 2.02M | 2.10M | 1.78M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 14.37M | 0 | 2.08M | 0 |
Other non-current assets | 2.91M | 1.98M | 2.41M | 2.43M | -16.32M | -15.04M | -15.02M | -13.75M | 483K | 1.44M |
Total non-current assets | 31.34M | 30.55M | 30.23M | 31.05M | 16.32M | 15.04M | 15.02M | 13.75M | 14.72M | 15.70M |
Total assets | 64.82M | 72.94M | 88.08M | 86.22M | 68.49M | 51.01M | 56.67M | 50.69M | 27.75M | 30.62M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | -694K | -644K | -295K | -251K | 0 | 0 |
Short term debt | 2.11M | 2.26M | 1.75M | 2.26M | 694K | 644K | 295K | 251K | 1.42M | 2.79M |
Total current liabilities | 20.54M | 18.05M | 18.23M | 18.22M | 16.85M | 14.63M | 12.52M | 7.42M | 7.74M | 11.14M |
| Non-current liabilities: | ||||||||||
Long term debt | 28.87M | 1.49M | 2.45M | 2.92M | 1.74M | 2.41M | 3.07M | 1.43M | 97K | 12.36M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 201K |
Other non-current liabilities | 11.70M | 8.46M | 11.49M | 13.83M | -1.74M | 10.62M | 10.76M | 7.37M | 5.15M | 4.77M |
Total non-current liabilities | 40.57M | 17.13M | 21.32M | 24.21M | 1.74M | 2.41M | 3.07M | 1.43M | 5.41M | 17.33M |
Total liabilities | 61.11M | 35.18M | 39.55M | 42.44M | 30.93M | 27.98M | 26.35M | 16.23M | 13.16M | 28.48M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |